Search by Drug Name or NDC

NDC 68382-0618-14 aspirin-dipyridamole 25; 200 mg/1; mg/1 Details

aspirin-dipyridamole 25; 200 mg/1; mg/1

aspirin-dipyridamole is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is ASPIRIN; DIPYRIDAMOLE.

MedlinePlus Drug Summary

The combination of aspirin and extended-release dipyridamole is in a class of drugs called antiplatelet agents. It works by preventing excessive blood clotting. It is used to reduce the risk of stroke in patients who have had or are at risk of stroke.

Related Packages: 68382-0618-14
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Aspirin and Extended-Release Dipyridamole

Product Information

NDC	68382-0618
Product ID	68382-618_79e77a71-5dcf-48ac-8483-a8540a112457
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	aspirin-dipyridamole
Proprietary Name Suffix	n/a
Non-Proprietary Name	aspirin-dipyridamole
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	25; 200
Active Ingredient Units	mg/1; mg/1
Substance Name	ASPIRIN; DIPYRIDAMOLE
Labeler Name	Zydus Pharmaceuticals USA Inc.
Pharmaceutical Class	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregati
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA206753
Listing Certified Through	2024-12-31

Package

NDC 68382-0618-14 (68382061814)

Pricing Information	N/A
NDC Package Code	68382-618-14
Billing NDC	68382061814
Package	60 CAPSULE in 1 BOTTLE (68382-618-14)
Marketing Start Date	2018-01-04
NDC Exclude Flag	N